Eczema drug trial halted early: what we know
Symptom relief
Terminated
This study tested an experimental drug called IMG-007 in 13 adults with moderate-to-severe eczema (atopic dermatitis) who didn't get enough relief from topical treatments. The main goal was to check the drug's safety, and researchers also looked at how the body processes it and w…
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Symptom relief
Last updated May 17, 2026 02:22 UTC